Addressing COVID-19 Vaccine Hesitancy in Patients with IBD-Reference-Cited by-同舟云学术

Addressing COVID-19 Vaccine Hesitancy in Patients with IBD

Published:2021-09-24 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Hudhud Dania¹,Caldera Freddy²^ORCID,Cross Raymond K¹^ORCID

Affiliation:

1. University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD, USA

2. Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Abstract

Lay Summary It is recommended that all patients with IBD undergo vaccination against COVID-19. In this commentary, we encourage IBD providers to serve as vaccine advocates and suggest implementing different methods for battling misinformation, paying careful attention to minority population.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izab241/40436355/izab241.pdf

Reference17 articles.

1. Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients undergoing transcatheter mitral valve repair;Azzalini;Catheter Cardiovasc Interv.,2016

2. Adverse events after SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease [published online ahead of print, June 21, 2021];Botwin;Am J Gastroenterol.,2021

3. Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial;Caldera;Inflamm Bowel Dis.,2020

4. Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease [published online ahead of print, June 15, 2021];Kappelman;Gastroenterology.,2021

5. Elevated adherence to vaccination against SARS-CoV-2 among patients with inflammatory bowel disease [published online ahead of print, June 15, 2021];Giannini;J Crohns Colitis.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale;Human Vaccines & Immunotherapeutics;2024-05-16

2. COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease;Vaccines;2022-12-05

3. Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan;Digestive Diseases and Sciences;2022-09-30

4. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study;Vaccines;2022-07-22

5. COVID-19 Vaccine Booster Dose Willingness Among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study;2022-07-18